Sermorelin is shown to increase lean muscle mass by up to 20%
and decrease body fat by 10% over 6–12 months of therapy.
Tesamorelin
Tesamorelin therapy has demonstrated an 18% reduction in
visceral abdominal fat over 6 months in treated individuals.
CJC-1295/Ipamorelin
Users have reported an increase of up to 5–10 pounds of lean
muscle after 8–12 weeks, along with significant reductions in body fat.
Sermorelin/Ipamorelin
Combined therapy can increase IGF-1 levels by up to 60% and
improve recovery times and muscle mass within 3–6 months.
IGF-1 LR3
Advanced peptide stacking can increase lean muscle mass by
10–20% and decrease recovery time from workouts or injuries by 30–40% in dedicated
users.
CJC-1295/Ipamorelin/IGF-1 LR3
Advanced peptide stacking can increase lean muscle mass by
10–20% and decrease recovery time from workouts or injuries by 30–40% in dedicated
users.
SS-31
Early studies show SS-31 can increase mitochondrial energy
output by 20–30%, improving endurance and reducing muscle fatigue.
BPC-157
BPC-157 has been associated with up to 50% faster healing of
muscle and tendon injuries in preclinical and pilot human studies.
TB-500 (Thymosin β4)
In Phase II wound-healing trials, thymosin β4 accelerated healing
by nearly one month, with ~25% of patients achieving
complete closure within three months.
Never Miss an IVÉ Moment
Get exclusive wellness tips, member perks,
and the latest IVÉ updates—delivered right to your inbox.
